发明名称 sFRP expression enhancing agent
摘要 Tumor formation and reduced transcription of both sFRP1 gene and sFRP2 gene were found in Dlg gene knock-out mice, and thereby the following has been provided: an agent for enhancing the expression and/or function of sFRP, containing a compound having an effect of enhancing the expression and/or function of Dlg; an agent for inhibiting tumor formation or an agent for preventing and/or treating a tumor disease, containing the agent for enhancing the expression and/or function of sFRP; a method of enhancing the expression and/or function of sFRP, comprising enhancing the expression and/or function of Dlg; a method of inhibiting tumor formation or a method of preventing and/or treating a tumor disease, comprising using the aforementioned enhancing agent or the aforementioned enhancing method; a non-human mammal that is deficient in one or both of Dlg alleles; a cell originating in the mammal; a method of identifying a compound, comprising using the mammal or the cell; and a method of examining a tumor tissue or a tumor cell, comprising measuring the expression and/or function of Dlg.
申请公布号 US7705196(B2) 申请公布日期 2010.04.27
申请号 US20050594695 申请日期 2005.03.30
申请人 DAIICHI PHARMACEUTICAL CO., LTD. 发明人 AKIYAMA TETSU;ISHIDAO TAKEFUMI;AIBA TOMOIKI
分类号 G01N33/00;A61K38/00;A61K45/00;A61K48/00;A61P35/00;C12N5/10;C12N15/09;C12N15/85;C12Q1/00;C12Q1/02;C12Q1/68;G01N33/53;G01N33/574 主分类号 G01N33/00
代理机构 代理人
主权项
地址